Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole vs Linezolid/Ceftazidime in Nosocomial Pneumonia
NCT00210964Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Apr 2005
- Primary completion
- May 2007
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftobiprole medocaril in hospital-acquired pneumonia (HAP), sponsored by Basilea Pharmaceutica. Started Apr 2005; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT00210964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210964.